Please login to the form below

Not currently logged in
Email:
Password:

Celgene plans real-world study using Apple's ResearchKit

Will develop an iPhone app to assess burden of chronic anaemia
Celgene

Celgene is planning to use Apple's ResearchKit framework for an observational study into the burden of chronic anaemia in two blood disorders.

Working on the project with biomedical research organisation Sage Bionetworks, Celgene aims to collect difficult-to-quantify data in myelodysplastic syndromes and beta-thalassemia.

The partners' mobile study will also collect neurological assessments of patients using cognitive testing software from BrainBaseline, technology that allows self-assessment of cognitive performance.

Celgene said its app would additionally support patients living with their disease and allow them to understand their physical functioning and other symptoms of anaemia.

Michael Pehl, president of hematology and oncology for Celgene, said: "We stand at a point where technology is unlocking the ability to capture patient reported outcomes.

"Through our collaboration with Sage Bionetworks and the evolving capability of smartphones and wearables as robust data collection devices, we believe we will be able to provide important new insights for patients with MDS and beta-thalassemia."

Myelodysplastic syndromes and beta-thalassemia typically have clinical endpoints outside traditional measures.

The project will see Celgene and Sage work with patient groups the MDS Foundation and Cooleys Anemia Foundation on defining the right elements for the mobile app to capture in order to ensure it is relevant for patients.

Dr Lara Mangravite, president of Sage Bionetworks, said: "We are thrilled to partner with Celgene to explore the use of sensor-based technologies to quantify the daily burden of disease in patients with chronic anaemia. This is a first of its kind exploration from which we hope to gain insights that can be used to understand the impact of chronic anaemia."

ResearchKit helps users to gather data more frequently and more accurately from study participants using iPhone apps. The open source framework also allows those taking part in studies to review an interactive informed consent process, submit survey responses and choose how their health data is shared with researchers.

Researchers can also, with the user's permission, use ResearchKit to access data from Apple's Health iPhone app, opening up a potential treasure trove of real-time data on weight, blood pressure, glucose levels, and other data measured by third-party devices and apps.

The technology is being used in academic studies in autism, epilepsy and melanoma, and earlier this year GlaxoSmithKline launched the first industry trial powered by ResearchKit for an arthritis study.

Article by
Dominic Tyer

19th October 2016

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Women in science
The role of women in science and technology
Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
Maria Dahl
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China secures a place at the forefront of innovative medicine...
Virtual Research Grants Submission and Approval Program
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....

Infographics